Clinical Trials in Massachusetts

Showing 8081-8100 of 13,570 trials

COMPLETEDNA20 miles

Soliton Planar Acoustic Wave Device System for Dermal Clearing Human Trial Protocol

NCT02877667

Study of new acoustic wave device as an accessory to laser treatment in tattoo reduction.

Tattoo

Soliton40 participantsStarted Jul 2016

Chestnut Hill, Massachusetts, United States

COMPLETEDNA20 miles

A Safety and Effectiveness Study of JUVÉDERM VOLUMA® XC Injectable Gel for Chin Augmentation

NCT02833077

This is a safety and effectiveness study of JUVÉDERM VOLUMA XC injectable gel for chin augmentation to correct volume deficit in chin retrusion.

Chin Retrusion

Allergan221 participantsStarted Jun 2016

San Diego, California, United States • Coral Gables, Florida, United States • Miami Beach, Florida, United States +11 more locations

COMPLETEDPhase 320 miles

An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia

NCT02234583

This is an open-label study of DS-5565 in subjects who either completed participation in a preceding Phase 3 study of DS-5565 in fibromyalgia (FM); i.e. DS5565-A-E309 (NCT02146430), DS5565-A-E310 (NCT02187471), or DS5565-A-E311 (NCT02187159) or are de novo subjects. Eligible subjects will be assigned to receive open-label DS-5565 for 52 weeks. All subjects will receive DS-5565 15 mg once daily (QD) for the first three weeks of the treatment period. After three weeks, subjects may be titrated to 15 mg twice daily (BID) based on protocol-specified criteria.

Pain Associated With Fibromyalgia

Daiichi Sankyo2,485 participantsStarted Feb 2015

Birmingham, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +273 more locations

Soliton Planar Acoustic Wave Device System for Dermal Clearing Human Trial Protocol

A Safety and Effectiveness Study of JUVÉDERM VOLUMA® XC Injectable Gel for Chin Augmentation

An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia

Find Trials by Condition in Massachusetts

Study of Ataluren (PTC124) in Nonambulatory Participants With Nonsense-Mutation-Mediated Duchenne/Becker Muscular Dystrophy (nmDMD/BMD)

Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy

Study of Urate Elevation in Parkinson's Disease, Phase 3

A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function

A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)

Effect of Ketamine on Opioid-Induced Hyperalgesia

Seizure Activity in Alzheimer's Disease

Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.

A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC)

Nilotinib in Parkinson's Disease

A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis

A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration

Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement

Prospective Cohort Study of Accelerated Resolution Therapy (ART) for Treatment of Military Psychological Trauma

A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor

IMCgp100-401 Rollover Study

Study to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adults Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I